Progress and Challenges in Targeting BRAFV600E-mutant Colorectal Cancer: Molecular Pathogenesis, Treatment Strategies, and Future Directions - My Experience at Johns Hopkins University
{{output}}
Colorectal cancer (CRC) remains a major global health challenge, with the BRAFV600E mutation representing one of the most aggressive and treatment-resistant subtypes. This review focuses on the molecular pathogenesis, clinical implications, and evolving therap... ...
